The Role of Vitamin D in Vogt-Koyanagi-Harada Disease
Author Information
Author(s): Yi Xianglong, Yang Peizeng, Sun Min, Yang Yan, Li Fuzhen
Primary Institution: Zhongshan Ophthalmic Center, Sun Yat-sen University
Hypothesis
Decreased levels of 1,25-Dihydroxyvitamin D3 are involved in the pathogenesis of Vogt-Koyanagi-Harada disease.
Conclusion
The study suggests that lower levels of 1,25(OH)2D3 may contribute to the development of VKH disease and that it could be a potential treatment option.
Supporting Evidence
- 1,25(OH)2D3 levels were significantly lower in active VKH patients compared to inactive patients and controls.
- 1,25(OH)2D3 inhibited the proliferation of PBMCs and CD4+ T cells.
- 1,25(OH)2D3 reduced the production of IL-17 and IFN-γ in VKH patients.
Takeaway
This study found that people with a certain eye disease have lower levels of a vitamin that helps the immune system, which might make the disease worse.
Methodology
Blood samples were taken from VKH patients and healthy individuals to measure serum 1,25(OH)2D3 levels and assess cell proliferation and cytokine production.
Limitations
The study was limited to a specific population and may not be generalizable to all VKH patients.
Participant Demographics
25 VKH patients (13 men, 12 women) with an average age of 38.4 years and 16 healthy controls (9 men, 7 women) with an average age of 40.5 years.
Statistical Information
P-Value
p=0.038 for active vs inactive VKH patients; p=0.001 for active VKH patients vs controls
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website